Belmont, CA, United States of America

Devika Ashok

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Arcus Biosciences, Inc.. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Devika Ashok: Innovator in Cancer Treatment

Introduction

Devika Ashok is a notable inventor based in Belmont, CA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development. Her work focuses on utilizing an identified adenosine fingerprint to improve therapeutic methods for cancer patients.

Latest Patents

Devika Ashok holds 1 patent for her invention titled "Treatment of cancer utilizing an identified adenosine fingerprint." This patent outlines methods for treating cancer by assessing the blood concentration and enzymatic activity of adenosine machinery proteins. The methods also include evaluating tumor expression levels of these proteins. The therapeutic agents proposed in her patent target the extracellular production of adenosine and antagonize the activation of adenosine receptors.

Career Highlights

Devika is currently employed at Arcus Biosciences, Inc., where she continues to advance her research in cancer therapies. Her innovative approach has the potential to significantly impact the treatment landscape for cancer patients.

Collaborations

Devika collaborates with talented professionals in her field, including Amy Elizabeth Anderson and Daniel M DiRenzo. Their combined expertise fosters a productive environment for groundbreaking research.

Conclusion

Devika Ashok's contributions to cancer treatment through her innovative patent demonstrate her commitment to improving patient outcomes. Her work at Arcus Biosciences, Inc. highlights the importance of collaboration in advancing medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…